SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Referencias del artículo

KICKLIGHTER, Caroline E.; NELSON, Kent M.; HUMPHRIES, Tammy L.  y  DELATE, Thomas. Evaluación de una intervención de farmacia clínica sobre el control de la presión arterial. Pharmacy Pract (Granada) [online]. 2006, vol.4, n.3, pp.110-116. ISSN 1885-642X.

    1. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense H, Joffres M, et al. Hypertension and blood pressure levels in 6 European countries, Canada, and the US. JAMA 2003; 289: 2363–2369. [ Links ]

    2. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997; 349: 1436–1442. [ Links ]

    3. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke, and coronary heart disease. Part 2: short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827-38. [ Links ]

    4. Neal B, MacMahon S, Chapman N. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists’ Collaboration. Lancet 2000;356:1955-64. [ Links ]

    5. Hajjar I, Kitchen TA. Trends in prevalence awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003;290:199-206. [ Links ]

    6. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004;43:10-17. [ Links ]

    7. Berlowitz DR, Ash AS, Hickey EC, Friedman RH, Glickman M, Kader B, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med 1998;339:1957-63 [ Links ]

    8. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Eng J Med 2001;345:479-86. [ Links ]

    9. Vivian EM. Improving blood pressure control in a pharmacist-managed hypertension clinic. Pharmacotherapy 2002;22:1533-40. [ Links ]

    10. Borenstein JE, Graber G, Saltiel E, Wallace J, Seonyoung R, Jackson A. Physician-pharmacist comanagement of hypertension: a randomized, comparative trial. Pharmacotherapy 2003:23:209-16. [ Links ]

    11. Bogden PE, Abbott Rd, Williamson P, Onopa JK, Koontz LM. Comparing standard care with a physician and pharmacist team approach for uncontrolled hypertension. J Gen Intern Med 1998;13:740-5. [ Links ]

    12. Mehos BM, Saseen JJ, MacLaughlin EJ. Effect of pharmacist intervention and initiation of home blood pressure monitoring in patients with uncontrolled hypertension. Pharmacotherapy 2000;20:1384-9. [ Links ]

    13. Alsuwaidan S, Malone DC, Billups SJ, Carter BL. Characteristics of ambulatory care clinics and pharmacists in Veterans Affairs Medical Centers. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers, IMPROVE investigators. Am J Health Syst Pharm 1998;55:68-72. [ Links ]

    14. National High Blood Pressure Education Program. The fifth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1993;153:154-83. [ Links ]

    15. Gosse P, Bougaleb M, Egloff P, Lemetayer P, Clementy J. Clinical significance of white-coat hypertension. J Hypertens 1994;12(8):S43-7. [ Links ]

    16. Kramarow E, Lentzner H, Rooks R, Weeks J, Sayday S. Health and aging chart book: health, United States, 1999. Hyattsville, MD: National Center for Health Statistics, 1999. [ Links ]

    17. The sixth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997;157:2413-46. [ Links ]

    18. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Isso JL, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003;42:1206-1252. [ Links ]

    19. Fischer MA, Avorn J. Economic implications of evidence-based prescribing for hypertension. Can better care cost less? JAMA 2004;291:1850-6. [ Links ]

    20. Cheng C, Studdifor JS, Chambers CV, Diamond JJ, Paynter N. The reliability of patient self-reported blood pressures. J Clin Hypertens 2002;4:259-64. [ Links ]